Loading...
Curamik Expansion Risks And EV Demand Uncertainty Will Pressure Margins And Earnings Outlook
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
21 Jan 26
Views
6
21 Jan
US$133.00
AnalystLowTarget's Fair Value
US$85.00
56.5% overvalued intrinsic discount1Y
99.6%7D
-7.1%1Y
99.6%7D
-7.1%You can edit this narrative until Jan 22 8:10 PM. Then, changes will post as Updates.
Author's Valuation
US$8556.5% overvalued intrinsic discount
AnalystLowTarget Fair Value